These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12370077)

  • 1. Highlights in the development of new antiviral agents.
    De Clercq E
    Mini Rev Med Chem; 2002 Apr; 2(2):163-75. PubMed ID: 12370077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New developments in anti-HIV chemotherapy.
    De Clercq E
    Curr Med Chem; 2001 Nov; 8(13):1543-72. PubMed ID: 11562282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New anti-HIV agents and targets.
    De Clercq E
    Med Res Rev; 2002 Nov; 22(6):531-65. PubMed ID: 12369088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral drugs in current clinical use.
    De Clercq E
    J Clin Virol; 2004 Jun; 30(2):115-33. PubMed ID: 15125867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging antiviral drugs.
    De Clercq E
    Expert Opin Emerg Drugs; 2008 Sep; 13(3):393-416. PubMed ID: 18764719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New developments in anti-HIV chemotherapy.
    De Clercq E
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):258-75. PubMed ID: 12084468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging anti-HIV drugs.
    De Clercq E
    Expert Opin Emerg Drugs; 2005 May; 10(2):241-73. PubMed ID: 15934866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral drugs: current state of the art.
    De Clercq E
    J Clin Virol; 2001 Aug; 22(1):73-89. PubMed ID: 11418355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge.
    De Clercq E
    Biochem Pharmacol; 2007 Apr; 73(7):911-22. PubMed ID: 17045247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral agents: characteristic activity spectrum depending on the molecular target with which they interact.
    De Clercq E
    Adv Virus Res; 1993; 42():1-55. PubMed ID: 8430518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral drug discovery and development: where chemistry meets with biomedicine.
    De Clercq E
    Antiviral Res; 2005 Aug; 67(2):56-75. PubMed ID: 16046240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hamao Umezawa Memorial Award Lecture: "An Odyssey in the Viral Chemotherapy Field".
    De Clercq E
    Int J Antimicrob Agents; 2001 Oct; 18(4):309-28. PubMed ID: 11691563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Discovery of Nucleos(t)ide Antiviral Agents: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Birthday.
    Li G; Yue T; Zhang P; Gu W; Gao LJ; Tan L
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33572409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cutting-edge view on the current state of antiviral drug development.
    De Clercq E
    Med Res Rev; 2013 Nov; 33(6):1249-77. PubMed ID: 23495004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2001 ASPET Otto Krayer Award Lecture. Molecular targets for antiviral agents.
    De Clercq E
    J Pharmacol Exp Ther; 2001 Apr; 297(1):1-10. PubMed ID: 11259521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective virus inhibitors.
    De Clercq E
    Microbiologica; 1990 Apr; 13(2):165-78. PubMed ID: 1693749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-chemotherapy and -prophylaxis: new drugs, leads and approaches.
    De Clercq E
    Int J Biochem Cell Biol; 2004 Sep; 36(9):1800-22. PubMed ID: 15183346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome.
    Barbaro G; Scozzafava A; Mastrolorenzo A; Supuran CT
    Curr Pharm Des; 2005; 11(14):1805-43. PubMed ID: 15892677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curious discoveries in antiviral drug development: the role of serendipity.
    De Clercq E
    Med Res Rev; 2015 Jul; 35(4):698-719. PubMed ID: 25726922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
    De Clercq E
    Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.